LDS/Medical Tests/Immunoglobulin D (IgD)

Immunoglobulin D (IgD)

Immunoglobulin D (IgG) is a member of immunoglobulin family with very low serum concentration. Although, IgD represents about 0.25% of the total serum immunoglobulins IgD serves as an important lymphocyte receptor in activation of B lymphocytes antibody production. IgD is composed of of two heavy and two light chains and it is major surface immunoglobulin of B lymphocytes. It has a short half-life of less than 3 days and does not cross the placenta. Antibody activity of IgD against antigens is broad and has been shown to play important role in innate immunity especially in mucosal lining.
IgD producing myeloma are rare but can occur with less than 2% reported cases. Looking for an IgD monoclonal protein in serum electrophoresis might by rare, but might be needed in cases with an abnormal band but no reactivity with antibodies against the other heavy chain types in immunofixation. Increased IgD serum levels might occur in polyclonal and monoclonal forms, depending on the immunoglobulin production by lymphocytes and the disease or disorder. Increases in polycolonal IgD are seen in smokers, infections (including AIDS and acute viral hepatitis) and in patients with chronic obstructive pulmonary disease. Increase in monoclonal is seen in multiple myeloma, and monoclonal gammopathy of undetermined significance (MGUS). Decreased levels of IgD are seen in hereditary or acquired deficiency syndromes. There are several methods of measuring IgD levels in serum including Nephelometry, Radioimmunoassay (RIA) and electrophoresis, with nephelometry been most common.

  • Investigation of monoclonal gammopathy for diagnosis of IgD myeloma
  • Disease management and therapy monitoring

Increased in:

  • Septicemia
  • Sarcoidosis
  • Multiple Myeloma (IgD type)
  • Subacute Thyroiditis
  • Multiple Sclerosis
  • Monoclonal gammopathy of undetermined significance
  • Polyarteritis Nodosa
  • Systemic Lupus Erythematosus
  • Dermatomyositis
  • Rheumatoid Arthritis
  • Hemolytic Disease of Newborn
  • Chronic Fatigue Syndrome

Decreased in:

  • Malignant Melanoma of Skin
  • Agammaglobulinemia
  • Hereditary or acquired deficiency syndrome
  • Pre-eclampsia

Newborn < 1 mg/dL

Adult: <10mg/dL

Nephelometry, Radioimmunoassay (RIA).

Serum (SST). 

Stability

  • Ambient: 48 hours
  • Refrigerated: 7 days
  • Frozen: 28 days
Immunoglobulin IgG, IgA, IgM if indicated. Protein electrophoresis and Immunoelectrophoresis.
1-3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Clin Diagn Lab Immunol. 2000 Mar; 7(2): 131–140. [PMID: 10702483]
  • Mol Immunol. 2000 Oct;37(15):871-87. [PMID: 11282392]
  • Dev Comp Immunol. 2011 Dec;35(12):1309-16. [PMID: 21414345]
  • EMBO J. 1990 Feb;9(2):449-55. [PMID: 2303036]
  • J Clin Oncol 1994;12(11):2398-2404. [PMID: 7964956]
  • Alan H.B Wu. Tietz clinical guide to laboratory tests. 2006, Fourth edition. WB Saunders Company.
  • David S Jacobs et al. Laboratory test Handbook. 2001, 5th edition. Lexi-Comp Inc